Lv41
640 积分 2023-11-14 加入
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial
27天前
已完结
A Phase 2b, open-label, single arm, multicentre, pilot study of the efficacy, safety and tolerability of dostarlimab in women with early-stage MMR deficient endometrioid endometrial adenocarcinoma
1个月前
已关闭
Adenocarcinoma in situ of the uterine cervix: Clinical practice guidelines from the Italian society of colposcopy and cervical pathology (SICPCV)
1个月前
已关闭
First-line pyrotinib in advanced HER2-mutant non-small-cell lung cancer: a patient-centric phase 2 trial
1个月前
已完结
Journey of the elimination of cervical cancer in China
2个月前
已关闭
[Infection of human papillomavirus and head and neck cancer]
2个月前
已完结
Cervical Human Papillomavirus Prevalence in 5 Continents: Meta‐Analysis of 1 Million Women with Normal Cytological Findings
2个月前
已完结
Advances in the management of endometrial cancer
2个月前
已完结
Epidemiology of HPV-associated cancers past, present and future: towards prevention and elimination
3个月前
已完结
Neurological autoimmune disorders with prominent gastrointestinal manifestations: A review of presentation, evaluation, and treatment
1年前
已完结
皖公网安备34019202002308
